4.6 • 911 Ratings
🗓️ 10 January 2023
⏱️ 63 minutes
🧾️ Download transcript
Chris Rinsch is co-founder and CEO of Amazentis. For more than two decades, he has been an innovator in the life sciences arena. Before founding Amazentis in 2007, Rinsch worked in venture capital investing in pioneering life sciences companies in the nutrition space and in biotechnology developing cell-based therapies at the Swiss biotech company ISOTIS SA. Rinsch has authored original publications in leading scientific journals, including Nature Medicine, Nature Metabolism, Jama Open, Cell Reports Medicine and others, for his research on Urolithin A, mitochondrial health, muscle function, and joint health. Rinsch holds an MBA from INSEAD, France, a PhD in Cell and Molecular Biology from the University of Lausanne, a Master of Science in Biomedical Engineering from U.T. Southwestern Medical Center, and a Bachelor of Science in Engineering from Harvey Mudd College.
In this episode we discuss:
This episode is brought to you by Eight Sleep, Timeline Nutrition, Inside Tracker, 1st Phorm
Mentioned in this episode:
Inside Tracker 20% Off the Entire Store
https://info.insidetracker.com/drlyon
Visit 1st Phorm Website for Free Shipping
http://www.1stphorm.com/drlyon
Save $150 on the Eight Sleep Pod cover
https://eightsleep.com/drlyon
10% off your first order of Mitopure
https://timelinenutrition.com/DRLYON
Click on a timestamp to play from that location
0:00.0 | Welcome to the Dr. Gabrielle Lyon Show, where I believe a healthy world is based on transparent conversations. |
0:15.2 | In this episode, I interview Chris Rinch, and he's co-founder and CEO of Amazantus. |
0:21.5 | Now, it's very unusual for me to bring in a CEO or founder of a company unless I am deeply |
0:27.7 | invested and believe in the work that they are doing. |
0:30.6 | And that's exactly why I brought Chris on. |
0:34.8 | He has for more than two decades been an innovator in the life science areas. |
0:42.5 | And before founding Amazentis in 2007, he worked in venture capital investing in pioneering |
0:48.4 | life science companies in the nutrition space and in biotechnology developing cell-based therapies at the Swiss |
0:56.3 | biotech company. |
0:58.7 | Rinch has authored several original publications in leading scientific journals, including |
1:04.1 | nature medicine, nature metabolism, JAMA Open, cell reports medicine, and others. And what he has researched is this compound |
1:13.8 | called urolithin A. And urolithin A is being shown to have a significant impact on mitochondrial |
1:22.7 | health, muscle function, and joint health. This is exactly why I had him on. I absolutely believe in the |
1:29.9 | science that he's doing, and I wanted to hear it, quite frankly, from the horse's mouth. |
1:34.3 | In this episode, we talk all about urolithin A. We talk about what it takes to maintain healthy muscle, |
1:41.0 | what are some of the compounds and influences to really impact mitochondria, |
1:45.7 | and what we can learn from urolithin A and how it has the potential as it relates to health |
1:51.7 | and longevity and overall aging? |
1:54.5 | This episode is brought to you by eight sleep. |
1:57.2 | Do you struggle to fall asleep, wake up in the middle night, or argue with your partner over the |
2:01.5 | thermostat? Well, I personally do because my husband likes it 45 degrees in the room. And for me, |
2:08.0 | I like it a little bit warmer. We've really had this thing in our relationship where he likes to sleep |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Dr. Gabrielle Lyon, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Dr. Gabrielle Lyon and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.